Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

HIV commodities worth about Sh30 billion are lying at the Mombasa Road warehouses of the Mission for Essential Drugs & Supplies (MEDS), awaiting distribution, the NSDCC has said.The consignment ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Merck (NYSE:MRK) said that data from a pair of late-stage trials showed that an oral, two-drug regimen of ...

Merck (MRK) announced the presentation of “positive” results from two pivotal Phase 3 trials of the investigational, once-daily, oral, two-drug ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

large quantities of USAID and UNFPA -donated antiretroviral drugs and condoms meant to support Nigeria’s HIV/AIDS response, were found expired and repackaged for sale. She said these life-saving ...